title: Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents.
authors: Julie
authors: J
authors: Caron
authors: Carine
authors: C
authors: Michot
authors: Sylvie
authors: S
authors: Fabre
authors: Sylvain
authors: S
authors: Godreuil
authors: Bernard
authors: B
authors: Guillot
authors: Olivier
authors: O
authors: Dereure
mesh_terms: D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D015373:Bacterial Typing Techniques; D017291:Clarithromycin / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005385:Fingers / Q000382:microbiology; D005399:Fishes / Q000382:microbiology; D006229:Hand Dermatoses / Q000209:etiology / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D008911:Minocycline / Q000627:therapeutic use; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D019910:Mycobacterium marinum / Q000302:isolation & purification*; D017828:Rifabutin / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D017828:Rifabutin; D004977:Ethambutol; D000069285:Infliximab; D008911:Minocycline; D017291:Clarithromycin; D008727:Methotrexate